Categories Earnings Calls

Wells Fargo Company (WFC) Q3 2020 Earnings Conference Call

Listen to Wells Fargo Company (WFC) Q3 2020 earnings conference call dated Oct. 14, 2020

Corporate Participants:

John M. Campbell — Director of Investor Relations

Charles W. Scharf — Chief Executive Officer and President

John R. Shrewsberry — Senior Executive Vice President & Chief Financial Officer

Analysts:

Betsy Graseck — Morgan Stanley — Analyst

Matt O’Connor — Deutsche Bank — Analyst

Ken Usdin — Jefferies — Analyst

Erika Najarian — Bank of America Merrill Lynch — Analyst

John Pancari — Evercore ISI — Analyst

Saul Martinez — UBS — Analyst

Steven Chubak — Wolfe Research — Analyst

Vivek Juneja — J.P. Morgan — Analyst

Gerard Cassidy — RBC Capital Markets — Analyst

John McDonnell — Autonomous Research — Analyst

Read the full earnings call transcript here https://news.alphastreet.com/wells-fargo-co-wfc-q3-2020-earnings-call-transcript/

_________________________________________________________________________________________________________________

Stocks you may like:

Bank of America (BAC) Stock

Wells Fargo (WFC) Stock

JPMorgan Chase (JPM) Stock

Citigroup (C) Stock

Goldman Sachs (GS) Stock

Morgan Stanley (MS) Stock

_________________________________________________________________________________________________________________

Most Popular

PM Earnings: Key quarterly highlights from Philip Morris Q3 financial results

Philip Morris International Inc. (NYSE: PM) reported Third-quarter 2021 earnings results today. Net revenues increased 9% year-over-year to $8.1 billion. The reported net income amounted to $2.42 billion compared to

Halliburton stock slips on weaker-than-expected Q3 results

Halliburton (NYSE: HAL) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The company reported Q3 revenue of $3.9 billion, up 30% year-over-year and lower than the

Johnson & Johnson (JNJ) reports Q3 2021 earnings

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $23.3 billion, up 10.7% year-over-year, with operational

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top